Gijs Jochems, general manager of Promega Biotech Iberica, a leading molecular biology solutions provider, speaks about the company’s business transformation to collaborate with diverse areas of the private sector. Jochems goes on to give his insights on the state of Spanish innovation and highlights how Promega uses its commitment to CSR to build the scientific ecosystem of Spain.
Public money has been close to absent over the past decade; in order to keep sustainable, we needed to expand our business into private areas such as pharmaceutical, biotech, and agriculture
